Reliability and Validity of a Measure to Assess the Health-Related Quality of Life of Women with Alopecia Areata

February 2023 in “ Clinical and Experimental Dermatology ”

Huw Rees, Dmitri Wall, Laita Bokhari, Leila Asfour, Rodney Sinclair

TLDR The tool to measure life quality for women with alopecia is reliable and accurate.

We don't know much about this study yet.

We're maintaining the world's largest resposity of hair loss research. You can help out the community by sending a PDF of this study here . Not sure how to get a study's PDF? You can email the authors of the study.

View this study on academic.oup.com →

Discuss this study in the Community →

Research cited in this study

4 / 4 results

research Two Phase 3 Trials of Baricitinib for Alopecia Areata

148 citations, March 2022 in “The New England Journal of Medicine”

Baricitinib was effective in treating alopecia areata in two major trials.

research Tofacitinib for the Treatment of Severe Alopecia Areata and Variants: A Study of 90 Patients

238 citations, November 2016 in “Journal of The American Academy of Dermatology”

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

research Alopecia Areata and Health-Related Quality of Life: A Systematic Review and Meta-Analysis

128 citations, February 2016 in “British Journal of Dermatology”

Alopecia areata significantly lowers the quality of life, especially in emotional and mental health aspects.

research Development of a Health-Related Quality of Life Questionnaire for Women with Androgenetic Alopecia

31 citations, November 2000 in “Clinical and Experimental Dermatology”

WAA-QOL measures impact of hair loss on women's well-being.